Cite
HARVARD Citation
Mason, R. et al. (2020). Combined ipilimumab and nivolumab first‐line and after BRAF‐targeted therapy in advanced melanoma. Pigment cell & melanoma research. pp. 358-365. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mason, R. et al. (2020). Combined ipilimumab and nivolumab first‐line and after BRAF‐targeted therapy in advanced melanoma. Pigment cell & melanoma research. pp. 358-365. [Online].